Mer is a member of the TAM (Tyro3, Axl, Mer) kinase family that has been associated with cancer progression, metastasis, and drug resistance. Their essential function in immune homeostasis has prompted an interest in their role as modulators of antitumor immune response in the tumor microenvironment. Here we illustrate the outcomes of an extensive lead-generation campaign for identification of Mer inhibitors, focusing on the results from concurrent, orthogonal high-throughput screening approaches. Data mining, HT (high-throughput), and DECL (DNA-encoded chemical library) screens offered means to evaluate large numbers of compounds. We discuss campaign strategy and screening outcomes, and exemplify series resulting from prioritization of hits that were identified. Concurrent execution of HT and DECL screening successfully yielded a large number of potent, selective, and novel starting points, covering a range of selectivity profiles across the TAM family members and modes of kinase binding, and offered excellent start points for lead development.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.0c01904DOI Listing

Publication Analysis

Top Keywords

mer kinase
8
generating selective
4
selective leads
4
mer
4
leads mer
4
kinase inhibitors-example
4
inhibitors-example comprehensive
4
comprehensive lead-generation
4
lead-generation strategy
4
strategy mer
4

Similar Publications

A feeding-induced myokine modulates glucose homeostasis.

Nat Metab

January 2025

State Key Laboratory of Membrane Biology, MOE Key Laboratory of Bioinformatics, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.

Maintaining blood glucose homeostasis during fasting and feeding is crucial for the prevention of dysregulation that can lead to either hypo- or hyperglycaemia. Here we identified feimin, encoded by a gene with a previously unknown function (B230219D22Rik in mice, C5orf24 in humans), as a key modulator of glucose homeostasis. Feimin is secreted from skeletal muscle during feeding and binds to its receptor, receptor protein tyrosine kinase Mer (MERTK), promoting glucose uptake and inhibiting glucose production by activation of AKT.

View Article and Find Full Text PDF

Clonal hematopoiesis JAKs up plaque formation.

J Clin Invest

January 2025

Department of Medicine, Division of Hematology/Oncology, and.

Clonal hematopoiesis (CH) is a condition in which hematopoietic stem cells (HSCs) acquire mutations seen in leukemia. While individuals with CH generally do not show signs of hematologic disease, the condition becomes more common with age and correlates with age-related diseases, especially cardiovascular disease (CVD). JAK2 mutations in HSCs can lead to CH and correlate with atherosclerosis, but the condition has been difficult to study because of challenges modeling the mutant cells at very low frequency.

View Article and Find Full Text PDF
Article Synopsis
  • Aortic aneurysms and dissections (AAD) lead to over 10,000 deaths annually in the U.S., and currently, there are no effective medications to prevent them.
  • Researchers focused on ascending aortic aneurysms and dissections (AAAD) and explored the role of the MerTK receptor in endothelial cells as it relates to AAAD progression.
  • Utilizing advanced techniques like single-cell RNA sequencing and a specific mouse model lacking MerTK in endothelial cells, the study found that MerTK deficiency significantly increases the risk of AAAD by causing endothelial dysfunction and changes in smooth muscle cell behavior.
View Article and Find Full Text PDF
Article Synopsis
  • The NLRP3 inflammasome is important in liver diseases, but its specific function in liver regeneration is not well understood.
  • In a study with mice undergoing partial hepatectomy, it was found that inhibiting or removing NLRP3 improved liver regeneration, while increasing its levels hindered recovery.
  • The benefits of NLRP3 depletion are linked to the activation of certain macrophages, and using drugs to inhibit NLRP3 showed promise in improving liver regeneration, especially in mice on a high-fat diet.
View Article and Find Full Text PDF

Refining minimal engineered receptors for specific activation of on-target signaling molecules.

Sci Rep

December 2024

Laboratory of Cell Vaccine, Microbial Research Center for Health and Medicine (MRCHM), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki-Shi, Osaka, 567-0085, Japan.

Since designer cells are attracting much attention as a new modality in gene and cell therapy, it would be advantageous to develop synthetic receptors that recognize artificial ligands and activate solely signaling molecules of interest. In this study, we refined the construction of our previously developed minimal engineered receptors (MERs) to avoid off-target activation of STAT5 while maintaining on-target activation of signaling molecules corresponding to tyrosine motifs. Among the myristoylated, cytoplasmic, and transmembrane types of MERs, the cytoplasmic type had the highest signaling efficiency, although there was off-target activation of STAT5 upon ligand stimulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!